EU Vaccine Strategy

Pasākuma datums: 07/01/2021

Developing and deploying an effective and safe vaccine worldwide is likely to be the only way to end the COVID-19 pandemic. To this end, the Commission has proposed an EU vaccines strategy for COVID-19 and listed key steps for effective vaccination strategies and vaccine deployment.

The Commission has also entered into advance purchase agreements with several pharmaceutical laboratories in order to create a portfolio of potential vaccines against COVID-19 (Coronavirus). Any vaccine must be authorised by the European Medicines Agency (EMA) in accordance with safety and efficacy standards.

Ziņu vēsture

25/02/2021 16:00 - ENVI/ITRE - Meeting

Members of Committee on Environment, Public Health and Food Safety (ENVI) and Committee on Industry, Research and Energy (ITRE) participate in a joint meeting in the European Parliament in Brussels.

Rādīt tikai saistītos materiālus

10/02/2021 09:00 - Plenary session - Debate the state of play of the EU’s vaccination strategy

MEPs are expected to reiterate their support for a united EU approach to COVID-19 vaccines in a debate with Commission President von der Leyen.

Rādīt tikai saistītos materiālus

01/02/2021 14:45 - BUDG - Financing from the EU budget in the context of the EU vaccines strategy

Presentation by Sandra GALLINA, Director General for Health and Food Safety, DG SANTE, European Commission

Rādīt tikai saistītos materiālus

26/01/2021 17:30 - ENVI - Exchange of views with Emer COOKE, Executive Director of the European Medicines Agency

MEPs discuss during a meeting of the Committee on the Environment, Public Health and Food Safety

Rādīt tikai saistītos materiālus

19/01/2021 08:30 - Plenary session - Debate on EU global strategy on COVID-19 vaccinations

MEPs debate the need for more clarity and transparency regarding vaccine contracts, authorisation, availability and deployment of COVID-19 vaccines.